{
    "nct_id": "NCT05903131",
    "official_title": "A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia",
    "inclusion_criteria": "* Diagnosis of histologically confirmed complex atypical endometrial hyperplasia (AEH) or grade 1 endometrial cancer.\n\n  * Patients with a previous diagnosis of AEH or grade 1 endometrial cancer who are already being followed with conservative management with oral or LNG-IUD progestin therapy are eligible.\n  * For patients with a previous diagnosis of AEH or grade 1 endometrial cancer who have been placed on progestin prior to study entry, the duration of IUD or oral progestin use prior to trial entry should be documented.\n* Premenopausal woman with a uterus.\n* ECOG performance status of 0-2.\n* At least 18 years of age and no more than 45 years of age.\n* Interested in uterine preservation and/or fertility-sparing treatment.\n* BMI â‰¥ 30 kg/m^2.\n* Prior or current receipt of progestin is allowed as above. Willingness to undergo placement of LNG-IUD at the time of study entry.\n* Ability to understand and willingness to sign an IRB approved written informed consent document.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Current, active treatment for any malignant neoplasm with chemotherapy or radiation.\n* Pregnant and/or breastfeeding. Participants must have a negative urine or serum pregnancy test during screening window and within 7 days prior to LNG-IUD insertion. If LNG-IUD is in place, lack of pregnancy is assumed.\n* Active pelvic infection at the time of IUD placement or other contraindication to the use of an IUD in the opinion of the treating physician.",
    "miscellaneous_criteria": ""
}